Seres Therapeutics, Inc. (MCRB)

NASDAQ: MCRB · Real-Time Price · USD

4.480

-0.240 (-5.08%)

At close: Aug 13, 2026, 4:00 PM EDT

4.450

-0.030 (-0.67%)

After-hours: Aug 13, 2026, 7:34 PM EDT

Seres Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	15.59	45.77	30.79	127.97	163.03	180
Short-Term Investments	-	-	-	-	18.31	110.7
Cash & Short-Term Investments	15.59	45.77	30.79	127.97	181.34	290.71
Cash Growth	-65.64%	48.63%	-75.94%	-29.43%	-37.62%	14.62%
Accounts Receivable	0.27	0.16	-	-	-	-
Other Receivables	25	0.36	2.07	-	-	-
Total Trade Receivables	25.27	0.52	2.07	-	-	-
Other Current Assets	1.48	3.09	5.81	47.45	13.42	12.92
Total Current Assets	42.35	49.38	38.67	175.41	194.76	303.63
Net Property, Plant & Equipment	56.97	80.12	92.44	108.03	133.97	36.15
Long-Term Investments	-	-	-	-	-	0.5
Other Long-Term Assets	2.27	8.7	8.7	75.16	20.05	14.59
Total Assets	101.59	138.19	139.81	358.6	348.78	354.86
Accounts Payable	1.19	1.68	4.08	3.64	17.44	13.74
Accrued Expenses	7.02	7.25	28.47	22.51	59.84	45.09
Current Portion of Long-Term Debt	-	-	-	-	0.46	-
Current Portion of Leases	11.83	10.39	8.67	5.59	3.6	6.61
Unearned Revenue	-	-	-	-	4.26	16.82
Other Current Liabilities	-	-	-	66.92	-	-
Total Current Liabilities	20.03	19.32	41.22	98.66	85.6	82.26
Long-Term Debt	-	-	-	101.54	50.59	24.64
Long-Term Leases	44.82	72.58	82.97	91.65	107.94	17.96
Other Long-Term Liabilities	2.21	2.08	1.84	111.6	93.87	98.49
Total Long-Term Liabilities	47.02	74.65	84.8	304.8	252.41	141.09
Total Liabilities	67.05	93.98	126.03	403.46	338	223.35
Common Stock	0.01	0.01	0.01	0.14	0.13	0.09
Additional Paid-in Capital	1,022	1,017	991.87	933.24	875.18	745.83
Accumulated Other Comprehensive Income	-	-	-	-	-0.01	-0.06
Retained Earnings	-987.74	-972.4	-978.1	-978.24	-864.51	-614.35
Shareholders' Equity	34.53	44.22	13.78	-44.86	10.78	131.51
Total Liabilities & Equity	101.59	138.19	139.81	358.6	348.78	354.86
Total Debt	56.64	82.97	91.64	198.78	162.59	49.21
Net Cash (Debt)	-41.05	-37.2	-60.85	-70.82	18.75	241.5
Net Cash Growth	-	-	-	-	-92.23%	13.46%
Net Cash Per Share	-4.40	-4.19	-7.83	-11.06	3.47	52.67
Book Value	34.53	44.22	13.78	-44.86	10.78	131.51
Book Value Per Share	3.70	4.99	1.77	-7.01	2.00	28.68
Tangible Book Value	34.53	44.22	13.78	-44.86	10.78	131.51
Tangible Book Value Per Share	3.70	4.99	1.77	-7.01	2.00	28.68

SEC Filings: 10-K · 10-Q